{"id":202144,"name":"BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC","slug":"braeburn-inc-formerly-known-as-braeburn-pharmaceuticals-inc","state":"PA","country":"United States of America","description":"","totalSpending":1900000,"filings":17,"yearlySpending":[{"year":2018,"income":400000},{"year":2019,"income":600000},{"year":2020,"income":420000},{"year":2021,"income":480000}],"issues":["ALC","HCR","MMM","PHA","INS"],"firms":["BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC"],"lobbyists":["EDWARD BUCKLEY"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","Office of Natl Drug Control Policy (NDCP)","SENATE","Substance Abuse & Mental Health Services Administration (SAMHSA)","Drug Enforcement Administration (DEA)","Justice, Dept of (DOJ)","White House Office"],"sampleDescriptions":["HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S. 916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to ","HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S. 916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to ","HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S. 916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to ","HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S. 916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to ","HR 5202 - Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 , S. 916 - Protecting Patient Access to Emergency Medications Act of 2017: To amend the Controlled Substances Act to "],"years":[2018,2019,2020,2021]}